Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
This study has been completed.
Study NCT00289185   Information provided by GlaxoSmithKline
First Received: February 8, 2006   Last Updated: September 3, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Plasmodium Falciparum
Malaria
More general conditions related to this trial
Coccidiosis
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
Engerix-B
TETRActHib
GSK Malaria vaccine 257049 vaccine
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services